Press Releases - 2023-10-10 (1)

Date	Title	Company
10-Oct-2023	Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology	Valo Therapeutics
10-Oct-2023	GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1	GPCR Therapeutics
10-Oct-2023	Mission Therapeutics to Present at Michael J. Fox Foundation’s 15th Annual Parkinson’s Disease Therapeutics Conference	Mission Therapeutics
10-Oct-2023	Neoadjuvant study with LTX-315 in early-stage melanoma patients to be presented at the 15th Nordic melanoma meeting	Lytix Biopharma
10-Oct-2023	Ori Biotech to Present Scientific Data at 2023 Cell & Gene Meeting on the Mesa	Ori Biotech
10-Oct-2023	OrganaBio launches decentralized support division for vaccine and cell and gene therapy clinical trials	OrganaBio
10-Oct-2023	Otsuka announces Scottish Medicines Consortium acceptance of Lupkynis®(voclosporin) with mycophenolate mofetil for treating active lupus nephritis	Otsuka Pharmaceuticals
10-Oct-2023	Bulletin from Moberg Pharma´s Extraordinary General Meeting	Moberg Pharma
10-Oct-2023	Marathon Gold selects ABB as integrated process and power automation supplier for vital Valentine Gold Project	Marathon Gold
10-Oct-2023	New guidance launches to enhance quality and improve patient experience in healthcare sector	BSI
10-Oct-2023	Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention	Innovative Trials
10-Oct-2023	Life sciences leaders unite to condemn radical plans to rewrite medicines scheme	British Pharmaceutical Industry (ABPI)
10-Oct-2023	AstronauTx closes £48 million ($61 million) Series A financing to create new treatments for Alzheimer’s disease	AstronauTx Ltd
10-Oct-2023	Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer’s disease	Brandon Capital
10-Oct-2023	Pheon Therapeutics Appoints Oncology Expert Arvin Yang, MD, PhD as Chief Medical Officer	Pheon Therapeutics
10-Oct-2023	Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award	Novotech
10-Oct-2023	LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND AS ADJUVANT TREATMENT FOR PATIENTS WITH GERMLINE BRCA-MUTATED HER2-NEGATIVE HIGH RISK EARLY BREAST CANCER	AstraZeneca
10-Oct-2023	Copley launches a new blog for the pharmaceutical testing community	Copley Scientific
10-Oct-2023	Strong partners for a sustainable future in the pharmaceutical industry: Perlen Packaging and Etimex Primary Packaging join forces	Perlen Packaging
10-Oct-2023	Elsevier launches new PharmaPendium, empowering pharma companies to bring novel drugs to market faster and increase success of regulatory submissions	Elsevier